Literature DB >> 3871793

Sensitization to epithelial antigens in chronic mucosal inflammatory disease. Characterization of human intestinal mucosa-derived mononuclear cells reactive with purified epithelial cell-associated components in vitro.

J K Roche, C Fiocchi, K Youngman.   

Abstract

To explore the auto-reactive potential of cells infiltrating the gut mucosa in idiopathic chronic inflammatory bowel disease, intestinal lamina propria mononuclear cells (LPMC) were isolated, characterized morphologically and phenotypically, and evaluated for antigen-specific reactivity. The last was assessed by quantitating LPMC cytotoxic capabilities against purified, aqueous-soluble, organ-specific epithelial cell-associated components (ECAC) characterized previously. Enzyme-isolated inflammatory bowel disease LPMC were constituted primarily by T lymphocytes (57 +/- 12% OKT 3-positive), B lymphocytes (18 +/- 9% surface immunoglobulin-positive), and macrophages (11 +/- 6% esterase-positive), and were responsive to phytohemagglutinin (mean uptake 86,933 cpm/5 X 10(5) cells). LPMC present in abnormal segments from 71% of patients with chronic inflammatory bowel disease were cytotoxic for ECAC isolated from colon (12.5 +/- 8.9% specific lysis) and small bowel (7.1 +/- 6.5%), but not for kidney control antigen (0.8 +/- 1.1%) isolated in a manner analogous to that used for ECAC (P less than 0.02). In contrast, despite comparable responses to phytohemagglutinin (mean uptake 59,200 cpm/5 X 10(5) cells), LPMC from histologically normal mucosa of patients with benign (adult megacolon, Hirshsprung's disease, diverticulosis) or malignant disease failed to lyse indicator cells labeled with colon-derived ECAC (0.3 +/- 0.08%), small bowel-derived ECAC (0.4 +/- 1.11%), or kidney antigen (0.29 +/- 0.79%). LPMC reactivity for individual gel-purified macromolecules of small bowel-derived ECAC (designated as the "P" series of components) was greatest against component P1 (by 2-3-fold), but was detectable against three other purified components as well. The addition of patient's serum did not enhance cytotoxicity to ECAC. Characterization of the cytotoxic cell showed that it was nonadherent to plastic surfaces, bore T lymphocyte-specific markers detectable by OKT 11 and OKT 3 monoclonal antibodies, and could be depleted by removal of cells with receptors for sheep erythrocytes. ECAC-specific reactivity was markedly reduced (greater than 93%) in most experiments when LPMC were preincubated for 1 h with ECAC. These data support the concept that autosensitization to several epithelial cell-associated components has occurred in patients with chronic inflammatory bowel disease, and provide initial evidence that antigen-specific, cell-mediated mechanisms may play a role in the pathogenesis of these disorders.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871793      PMCID: PMC423527          DOI: 10.1172/JCI111728

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  An attempt at production of autoimmunity to tissue of the gastrointestinal tract.

Authors:  G S RICHARDSON; S LESKOWITZ
Journal:  Proc Soc Exp Biol Med       Date:  1961-02

2.  Gut mucosal lymphocytes in inflammatory bowel disease: isolation and preliminary functional characterization.

Authors:  C Fiocchi; J R Battisto; R G Farmer
Journal:  Dig Dis Sci       Date:  1979-09       Impact factor: 3.199

3.  Definitions of inflammatory bowel disease of unknown etiology.

Authors:  H Schachter; J B Kirsner
Journal:  Gastroenterology       Date:  1975-03       Impact factor: 22.682

4.  Chromic chloride: a coupling reagent for passive hemagglutination reactions.

Authors:  E R Gold; H H Fudenberg
Journal:  J Immunol       Date:  1967-11       Impact factor: 5.422

5.  Acid phosphatase isoenzyme in human leukocytes in normal and pathologic conditions.

Authors:  C Y Li; L T Yam; K W Lam
Journal:  J Histochem Cytochem       Date:  1970-07       Impact factor: 2.479

6.  Isolation and chemical characterization of the enterobacterial common antigen.

Authors:  D Männel; H Mayer
Journal:  Eur J Biochem       Date:  1978-05-16

7.  Experimental allergic aspermatogenic orchitis. III. Isolation of spermatozoal glycoproteins and their role in allergic aspermatogenic orchitis.

Authors:  A Hagopian; J J Jackson; D J Carlo; G A Limjuco; E H Eylar
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

8.  Human colonic mononuclear cells: studies of cytotoxic function.

Authors:  Z M Falchuk; E Barnhard; I Machado
Journal:  Gut       Date:  1981-04       Impact factor: 23.059

9.  Effect of lymphocytes from patients with ulcerative colitis on human adult colon epithelial cells.

Authors:  D W Watson; A Quigley; R J Bolt
Journal:  Gastroenterology       Date:  1966-12       Impact factor: 22.682

10.  Human colonic intraepithelial and lamina proprial lymphocytes: cytotoxicity in vitro and the potential effects of the isolation method on their functional properties.

Authors:  M Chiba; W Bartnik; S G ReMine; W R Thayer; R G Shorter
Journal:  Gut       Date:  1981-03       Impact factor: 23.059

View more
  14 in total

Review 1.  The immunology of inflammatory bowel disease.

Authors:  J R Lowes; D P Jewell
Journal:  Springer Semin Immunopathol       Date:  1990

2.  Enhanced peripheral blood T-cell cytotoxicity in inflammatory bowel disease.

Authors:  F Shanahan; B Leman; R Deem; A Niederlehner; M Brogan; S Targan
Journal:  J Clin Immunol       Date:  1989-01       Impact factor: 8.317

3.  Sensitization to epithelial antigens in chronic mucosal inflammatory disease: immunochemical similarity of macromolecules in human colonic epithelium with murine intestinal epithelial cell-associated components (ECAC).

Authors:  J W Paul; K W Kotz; J K Roche
Journal:  Immunology       Date:  1988-12       Impact factor: 7.397

Review 4.  The immunologic basis of inflammatory bowel disease.

Authors:  W Strober; S P James
Journal:  J Clin Immunol       Date:  1986-11       Impact factor: 8.317

5.  Phenotypic and functional characterization of T-cell lines generated from colonoscopic biopsy specimens in patients with ulcerative colitis.

Authors:  K Kusugami; J Haruta; M Ieda; M Shinoda; T Ando; A Kuroiwa; K Ina; H Iokawa; A Ishihara; S Sarai
Journal:  Dig Dis Sci       Date:  1995-01       Impact factor: 3.199

6.  Enzyme linked immunosorbent assay (ELISA) and immunoprecipitation studies on anti-goblet cell antibody using a mucin producing cell line in patients with inflammatory bowel disease.

Authors:  T Hibi; M Ohara; K Kobayashi; W R Brown; K Toda; H Takaishi; Y Hosoda; A Hayashi; Y Iwao; M Watanabe
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

7.  Intestinal mast cell responses in idiopathic inflammatory bowel disease. Histamine release from human intestinal mast cells in response to gut epithelial proteins.

Authors:  C C Fox; L M Lichtenstein; J K Roche
Journal:  Dig Dis Sci       Date:  1993-06       Impact factor: 3.199

Review 8.  Innate immunity in inflammatory bowel disease: a disease hypothesis.

Authors:  D J B Marks; A W Segal
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

9.  Population changes in immunoglobulin-containing mononuclear cells in dextran sulfate sodium-induced coltitis.

Authors:  S Tokoi; T Ohkusa; I Okayasu; K Nakamura
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

10.  Possible role of vascular endothelial cells in immune responses in colonic mucosa examined immunocytochemically in subjects with and without ulcerative colitis.

Authors:  T Matsumoto; A Kitano; S Nakamura; N Oshitani; A Obata; M Hiki; H Hashimura; K Okawa; K Kobayashi; H Nagura
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.